DDrare
Disease
Drug
Target Gene/Pathway
Contact
JA
Target Gene/Pathway
Pathway
/
Gene
Search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Other
Search results
10
50
100
ALL
entries per page:
Showing 1 to 10 of 13 entries
Filter by
Reset
No.
KEGG GENES
KEGG PATHWAY
KEGG DRUG
DrugBank
Disease ID
1
SV2C
[1]
ECM-receptor interaction
ECM-receptor interaction
D11842
D11842
Padsevonil
[1]
149
149
2
ITGA4
[11]
PI3K-Akt signaling pathway
PI3K-Akt signaling pathway
,
Focal adhesion
,
ECM-receptor interaction
,
Hematopoietic cell lineage
,
Leukocyte transendothelial migration
,
Intestinal immune network for IgA production
,
Regulation of actin cytoskeleton
,
Yersinia infection
,
Leishmaniasis
,
Human papillomavirus infection
,
Hypertrophic cardiomyopathy
[11]
PI3K-Akt signaling pathway
,
Focal adhesion
,
ECM-receptor interaction
,
Hematopoietic cell lineag
...
D06590
D06590
Firategrast
[1]
13
13
3
ITGA4
[11]
PI3K-Akt signaling pathway
PI3K-Akt signaling pathway
,
Focal adhesion
,
ECM-receptor interaction
,
Hematopoietic cell lineage
,
Leukocyte transendothelial migration
,
Intestinal immune network for IgA production
,
Regulation of actin cytoskeleton
,
Yersinia infection
,
Leishmaniasis
,
Human papillomavirus infection
,
Hypertrophic cardiomyopathy
[11]
PI3K-Akt signaling pathway
,
Focal adhesion
,
ECM-receptor interaction
,
Hematopoietic cell lineag
...
D06886
D06886
Natalizumab
[6]
13
13
,
15
,
25
,
46
,
63
,
96
4
ITGA4
[11]
PI3K-Akt signaling pathway
PI3K-Akt signaling pathway
,
Focal adhesion
,
ECM-receptor interaction
,
Hematopoietic cell lineage
,
Leukocyte transendothelial migration
,
Intestinal immune network for IgA production
,
Regulation of actin cytoskeleton
,
Yersinia infection
,
Leishmaniasis
,
Human papillomavirus infection
,
Hypertrophic cardiomyopathy
[11]
PI3K-Akt signaling pathway
,
Focal adhesion
,
ECM-receptor interaction
,
Hematopoietic cell lineag
...
D08083
D08083
Vedolizumab
[3]
94
94
,
96
,
97
5
ITGA4
[11]
PI3K-Akt signaling pathway
PI3K-Akt signaling pathway
,
Focal adhesion
,
ECM-receptor interaction
,
Hematopoietic cell lineage
,
Leukocyte transendothelial migration
,
Intestinal immune network for IgA production
,
Regulation of actin cytoskeleton
,
Yersinia infection
,
Leishmaniasis
,
Human papillomavirus infection
,
Hypertrophic cardiomyopathy
[11]
PI3K-Akt signaling pathway
,
Focal adhesion
,
ECM-receptor interaction
,
Hematopoietic cell lineag
...
D10540
D10540
Abrilumab
[2]
96
96
,
97
6
ITGB7
[8]
PI3K-Akt signaling pathway
PI3K-Akt signaling pathway
,
Focal adhesion
,
ECM-receptor interaction
,
Intestinal immune network for IgA production
,
Regulation of actin cytoskeleton
,
Human papillomavirus infection
,
Transcriptional misregulation in cancer
,
Hypertrophic cardiomyopathy
[8]
PI3K-Akt signaling pathway
,
Focal adhesion
,
ECM-receptor interaction
,
Intestinal immune network
...
D08083
D08083
Vedolizumab
[3]
94
94
,
96
,
97
7
ITGB7
[8]
PI3K-Akt signaling pathway
PI3K-Akt signaling pathway
,
Focal adhesion
,
ECM-receptor interaction
,
Intestinal immune network for IgA production
,
Regulation of actin cytoskeleton
,
Human papillomavirus infection
,
Transcriptional misregulation in cancer
,
Hypertrophic cardiomyopathy
[8]
PI3K-Akt signaling pathway
,
Focal adhesion
,
ECM-receptor interaction
,
Intestinal immune network
...
D09901
D09901
Etrolizumab
[2]
96
96
,
97
8
ITGB7
[8]
PI3K-Akt signaling pathway
PI3K-Akt signaling pathway
,
Focal adhesion
,
ECM-receptor interaction
,
Intestinal immune network for IgA production
,
Regulation of actin cytoskeleton
,
Human papillomavirus infection
,
Transcriptional misregulation in cancer
,
Hypertrophic cardiomyopathy
[8]
PI3K-Akt signaling pathway
,
Focal adhesion
,
ECM-receptor interaction
,
Intestinal immune network
...
D10540
D10540
Abrilumab
[2]
96
96
,
97
9
VWF
[6]
PI3K-Akt signaling pathway
PI3K-Akt signaling pathway
,
Focal adhesion
,
ECM-receptor interaction
,
Platelet activation
,
Neutrophil extracellular trap formation
,
Human papillomavirus infection
[6]
PI3K-Akt signaling pathway
,
Focal adhesion
,
ECM-receptor interaction
,
Platelet activation
,
Neutr
...
D11160
D11160
Caplacizumab
[1]
64
64
10
SV2B
[1]
ECM-receptor interaction
ECM-receptor interaction
D11842
D11842
Padsevonil
[1]
149
149